new melanoma drug – just listed on the pharmaceutical benefits scheme
Acral lentiginous melanoma of the sole, level 1. Source: Getty Images
A new treatment listed on the Pharmaceutical Benefits Scheme is said to reduce the recurrence of melanoma for half of stage three cancer patients
Share
